Dissociation of neuropathologic findings and cognition: Case report of an apolipoprotein E ε2/ε2 genotype

Archives of Neurology

Volumn 64, Issue 8, 2007, Pages 1193-1196

  Berlau, Daniel J ^a   Kahle Wrobleski, Kristin ^a   Head, Elizabeth ^a   Goodus, Matthew ^a   Kim, Ronald ^a   Kawas, Claudia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA TOCOPHEROL; APOLIPOPROTEIN E; ASCORBIC ACID; ATENOLOL; CALCIUM; ESTROGEN; HYDROCHLOROTHIAZIDE; LEVOTHYROXINE SODIUM; POTASSIUM CHLORIDE; RETINOL;

AGED; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CASE REPORT; COGNITIVE DEFECT; DEMENTIA; FEMALE; HUMAN; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; PRIORITY JOURNAL; SENILE PLAQUE;

AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; BRAIN; COGNITION; FEMALE; GENOTYPE; HUMANS; NEUROFIBRILLARY TANGLES; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; SENILE PLAQUES;

EID: 34547867338     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.8.1193     Document Type: Article

References (21)

1. Laws SM, Hone E, Gandy S, Martins RN. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem. 2003;84(6):1215-1236.
2. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240(4852):622-630.
3. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155(6):487-495.
4. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180-184.
5. West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett. 1994;175 (1-2):46-48.
6. Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology. 1997;48(2):515-519.
7. Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 1988;38(11):1682-1687.
8. Galvin JE, Powlishta KK, Wilkins K, et al. Predictors of preclinical Alzheimer's disease and dementia: a clinicopathologic study. Arch Neurol. 2005;62(5): 758-765.
9. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988;23(2):138-144.
10. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66(12):1837-1844.
11. Prohovnik I, Perl DP, Davis KL, Libow L, Lesser G, Haroutunian V. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology. 2006;66(1):49-55.
12. Paganini-Hill A, Ross RK, Henderson BE. Prevalence of chronic disease and health practices in a retirement community. J Chronic Dis. 1986;39(9):699-707.
13. Whittle C, Corrada MM, Dick M, et al. Neuropsychological data in nondemented oldest old: The 90+ Study. J Clin Exp Neuropsychol. 2007;29(3):290-299.
14. National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging. 1997;18(4)(suppl):S1-S2.
15. Yang DS, Smith JD, Zhou Z, Gandy SE, Martins RN. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J Neurochem. 1997;68(2):721-725.
16. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Proc Natl Acad Sci U S A. 1995;92(11):4725-4727.
17. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology. 2004;62(11):1977-1983.
18. Dodart JC, Marr RA, Koistinaho M, et al. Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2005;102(4):1211-1216.
19. Lee Y, Aono M, Laskowitz D, Warner DS, Pearlstein RD. Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity. Neurochem Int. 2004;44(2):107-118.
20. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet. 1996;14(1):55-61.
21. Love S, Siew LK, Dawbarn D, Wilcock GK, Ben-Shlomo Y, Allen SJ. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol Aging. 2006;27(6):797-803.